Replies to post #122004 on Biotech Values

[DewDiligence]

…too many lay people and investors do not appreciate the reduction in HbA1C levels of 1.5%-1.9%...

You have made this assertion several times in one form or another. What makes you think an HbA1c reduction of that magnitude is underappreciated by investors?